These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2117386)

  • 1. Effects of glyburide on carbohydrate metabolism and insulin action in the liver.
    Caro JF
    Am J Med; 1990 Aug; 89(2A):17S-25S; discussion 51S-53S. PubMed ID: 2117386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glyburide on hepatic glucose metabolism.
    McGuinness OP; discussion 51S-53S ; Cherrington AD
    Am J Med; 1990 Aug; 89(2A):26S-37S. PubMed ID: 2117387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glyburide on glycogen metabolism in cultured rat hepatocytes.
    Davidson MB; Sladen G
    Metabolism; 1987 Oct; 36(10):925-30. PubMed ID: 3116364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of englitazone and glyburide on gluconeogenesis and glycolysis in the isolated perfused rat liver.
    Adams MD; Raman P; Judd RL
    Biochem Pharmacol; 1998 Jun; 55(11):1915-20. PubMed ID: 9714310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glyburide sensitizes perfused rat liver to insulin-induced suppression of glucose output.
    McGuinness OP; Green DR; Cherrington AD
    Diabetes; 1987 Apr; 36(4):472-6. PubMed ID: 3102299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic modeling of human hepatic glucose metabolism in type 2 diabetes mellitus predicts higher risk of hypoglycemic events in rigorous insulin therapy.
    König M; Holzhütter HG
    J Biol Chem; 2012 Oct; 287(44):36978-89. PubMed ID: 22977253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.
    Wu C; Khan SA; Peng LJ; Li H; Carmella SG; Lange AJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E536-43. PubMed ID: 16621898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal interactions in carbohydrate metabolism.
    Geser CA
    Int Z Vitam Ernahrungsforsch Beih; 1976; 15():58-65. PubMed ID: 821893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Effects of Metformin in Humans.
    Adeva-Andany MM; Rañal-Muíño E; Fernández-Fernández C; Pazos-García C; Vila-Altesor M
    Curr Diabetes Rev; 2019; 15(4):328-339. PubMed ID: 30306875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glyburide but not ciglitazone enhances insulin action in the liver independent of insulin receptor kinase activation.
    Caro JF; Ittoop O; Sinha MK
    Metabolism; 1989 Jul; 38(7):606-11. PubMed ID: 2544783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallic acid ameliorates hyperglycemia and improves hepatic carbohydrate metabolism in rats fed a high-fructose diet.
    Huang DW; Chang WC; Wu JS; Shih RW; Shen SC
    Nutr Res; 2016 Feb; 36(2):150-60. PubMed ID: 26547672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus.
    Pedersen O; Hother-Nielsen O; Bak J; Hjollund E; Beck-Nielsen H
    Am J Med; 1991 Jun; 90(6A):22S-28S. PubMed ID: 1908182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.
    Suh KI; Murata C; Song YM; Joyce M; Gumbiner B; Ditzler TM; Henry RR
    J Clin Endocrinol Metab; 1993 Aug; 77(2):464-70. PubMed ID: 8345053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glyburide on beta cell responsiveness to glucose in non-insulin-dependent diabetes mellitus.
    O'Meara NM; Shapiro ET; Van Cauter E; Polonsky KS
    Am J Med; 1990 Aug; 89(2A):11S-16S; discussion 51S-53S. PubMed ID: 2117385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose oral glyburide reduces fasting blood glucose by decreasing hepatic glucose production in healthy volunteers without increasing carbohydrate oxidation.
    Tayek JA
    Am J Med Sci; 1995 Mar; 309(3):134-9. PubMed ID: 7879817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin regulation of gluconeogenesis.
    Hatting M; Tavares CDJ; Sharabi K; Rines AK; Puigserver P
    Ann N Y Acad Sci; 2018 Jan; 1411(1):21-35. PubMed ID: 28868790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glyburide on in vivo insulin-mediated glucose disposal.
    Simonson DC
    Am J Med; 1990 Aug; 89(2A):44S-50S; discussion 51S-53S. PubMed ID: 2117389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
    Simonson DC; Ferrannini E; Bevilacqua S; Smith D; Barrett E; Carlson R; DeFronzo RA
    Diabetes; 1984 Sep; 33(9):838-45. PubMed ID: 6432610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.